News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Gene-Testing Companies, Interleukin Genetics Inc., CyGene, Inc. May Need U.S. Regulators Review
July 22, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Interleukin Genetics Inc. and CyGene Laboratories Inc. are among 13 makers of genetic tests sold directly to consumers told by U.S. regulators that their products may be medical devices needing federal approval.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
MORE ON THIS TOPIC
FDA
Makary, Prasad Under Fire as FDA Turmoil Reaches President Trump
February 20, 2026
·
6 min read
·
Heather McKenzie
Vaccines
ACIP Meeting Delayed as Turbulence Rocks CDC, US Vaccine Policy
February 20, 2026
·
2 min read
·
Tristan Manalac
Regulatory
FDA’s Top Drug Regulator To Probe Safety of Antidepressants, RSV Antibodies
February 20, 2026
·
2 min read
·
Tristan Manalac
Government
Cassidy Names Areas of Improvement for FDA’s Regulatory ‘Black Box’
February 19, 2026
·
3 min read
·
Tristan Manalac